Výsledky vyhľadávania - "CD4 Lymphocyte Count/statistics & numerical data"

  • Zobrazené výsledky 1 - 7 z 7
Upresniť hľadanie
  1. 1
  2. 2

    Autori: Boatman, JA Baker, JV Emery, S a ďalší

    Zdroj: Boatman, Jeffrey A; Baker, Jason V; Emery, Sean; Furrer, Hansjakob; Mushatt, David M; Sedlacek, Dalibor; Lundgren, Jens D; Neaton, James D (2019). Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression among Participants Initiating Antiretroviral Treatment with CD4+ Counts > 500 cells/mm3: Findings from the Strategic Timing of AntiRetroviral Treatment (START) Trial. Journal of acquired immune deficiency syndromes JAIDS, 81(1), pp. 10-17. Wolters Kluwer Health 10.1097/QAI.0000000000001967 <http://dx.doi.org/10.1097/QAI.0000000000001967>

    Popis súboru: application/pdf

  3. 3

    Prispievatelia: Jun Yong Choi Nicole L. De La Mata Man Po Lee a ďalší

    Zdroj: International Journal of STD & AIDS. 28:1282-1291

  4. 4

    Zdroj: Journal of Clinical Epidemiology. 81:129-139

  5. 5

    Autori: Grint D Peters L Schwarze Zander C a ďalší

    Prispievatelia: Grint D Peters L Schwarze Zander C a ďalší

    Zdroj: HIV Med
    Journal of the International AIDS Society; Vol 15
    HIV MEDICINE
    Journal of the International AIDS Society
    HIV Medicine

    Predmety: LOW ELIGIBILITY, Liver Cirrhosis, Male, 0301 basic medicine, chronic - drug therapy, HIV Infections/complications/ drug therapy/virology, HIV Infections, LIVER FIBROSIS, Sjúklingar, Cohort Studies, 0302 clinical medicine, ANTIRETROVIRAL THERAPY, Liver cirrhosis - drug therapy, Liver cirrhosis - etiology, Medicine and Health Sciences, Skorpulifur, Poisson Distribution, Prospective Studies, Middle aged, Original Research, chronic - virology, Coinfection, Interferon-alpha/therapeutic use, Europe - epidemiology, Middle Aged, treatment completion, PLUS RIBAVIRIN, Hepatitis C, 3. Good health, Europe, HIV infections - complications, HUMAN-IMMUNODEFICIENCY-VIRUS, HCV, Combination, Cohort studies, Drug Therapy, Combination, Female, COINFECTION, Drug therapy, Adult, Alnæmi, ribavirin, Antiviral agents - therapeutic use, HIV infections - virology, HIV-INFECTED PATIENTS, Patient acceptance of health care - psychology, Antiviral Agents, EuroSIDA, Europe/epidemiology, Interferon-alpha - therapeutic use, 03 medical and health sciences, Drug Therapy, CD4 Lymphocyte Count/statistics & numerical data, Chronic/complications/ drug therapy/virology, Humans, Liver Cirrhosis/ drug therapy/etiology, Ribavirin, Lyfjameðferð, CD4 lymphocyte count - statistics & numerical data, Patient acceptance of health care - statistics & numercial data, chronic - complications, HCV coinfection, PEGYLATED INTERFERON-ALPHA-2B, HIV infections - drug therapy, combination, HIV, Interferon-alpha, Hepatitis C, Chronic, Patient Acceptance of Health Care, HIV/HCV coinfection, CD4 Lymphocyte Count, Ribavirin - therapeutic use, VIRAL CLEARANCE, PEG-interferon, Treatment completion, Infectious Diseases, Pharmacology (medical), Health Policy, Poisson distribution, Prospective studies

    Popis súboru: application/pdf

  6. 6
  7. 7

    Zdroj: INSIGHT START Study Group 2019 , ' Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression Among Participants Initiating Antiretroviral Treatment With CD4+ Counts > 500 Cells/mm3 : Findings From the Strategic Timing of AntiRetroviral Therapy (START) Trial ' , Journal of acquired immune deficiency syndromes (1999) , vol. 81 , no. 1 , pp. 10-17 .

    URL: https://researchprofiles.ku.dk/da/publications/risk-factors-for-low-cd4-count-recovery-despite-viral-suppression-among-participants-initiating-antiretroviral-treatment-with-cd4-counts--500-cellsmm3(a437133c-e79d-4a83-bed9-1be91425d17d).html
    https://doi.org/10.1097/QAI.0000000000001967
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456414/pdf/nihms-1517971.pdf